4//SEC Filing
Mallon Mark 4
Accession 0001077183-21-000256
CIK 0001077183other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:16 PM ET
Size
5.9 KB
Accession
0001077183-21-000256
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-12-06$30.63/sh+17,000$520,710→ 72,736 total
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (1)
- [F1]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001763533
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:16 PM ET
- Size
- 5.9 KB